Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
16.70
0.00 (0.00%)
Inactive · Last trade price on Jan 23, 2024

Orchard Therapeutics Analyst Ratings

Total Analysts
3
Consensus Rating
Buy
Price Target
$21.67
Upside
+29.76%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Stifel
Stifel
Hold
Downgrades
$16
HoldDowngrades$16-4.19%Oct 5, 2023
Oppenheimer
Oppenheimer
Buy
Reiterates
$34
BuyReiterates$34+103.59%Aug 9, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterates
$15
BuyReiterates$15-10.18%Jun 27, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$37$34
BuyMaintains$37$34+103.59%Jun 13, 2023
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$3$15
BuyMaintains$3$15-10.18%Mar 28, 2023
Barclays
Barclays
Buy
Maintains
$60$40
BuyMaintains$60$40+139.52%May 13, 2022
SMBC Nikko
SMBC Nikko
Hold
Downgrades
n/a
HoldDowngradesn/an/aApr 1, 2022
Cowen & Co.
Cowen & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aMar 31, 2022
JP Morgan
JP Morgan
Sell
Downgrades
n/a
SellDowngradesn/an/aNov 16, 2021
Oppenheimer
Oppenheimer
Buy
Maintains
n/a
BuyMaintainsn/an/aNov 5, 2021
JP Morgan
JP Morgan
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 18, 2021
JP Morgan
JP Morgan
Buy
Initiates
n/a
BuyInitiatesn/an/aMar 2, 2021
Oppenheimer
Oppenheimer
Buy
Maintains
n/a
BuyMaintainsn/an/aApr 1, 2020
Cowen & Co.
Cowen & Co.
Buy
Initiates
n/a
BuyInitiatesn/an/aNov 26, 2018